Condition: Ductal Carcinoma in Situ · Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Cryoablation or tumor freezing is a percutaneous, office-based procedure that is emerging as a minimally invasive, cost-effective alternative to surgery that is currently being evaluated in clinical trials for the management of for early-stage invasive breast cancer. The investigator will also evaluate the potential of cryoablation as a minimally invasive alternative to surgery for small areas of DCIS by examining its ability to achieve complete ablation of DCIS within the targeted cryoablation zone of necrosis.
This description comes directly from the study's public registry record.
Dennis R Holmes, M.D. · 800-203-5515 · drholmesmd50@gmail.com
Always discuss trial participation with your own doctor first.
| Office of Dennis R. Holmes, M.D., F.A.C.S. | Glendale, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05218044